Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRIMERA trial in newly diagnosed rheumatoid arthritis
2020-002802-21Phase 4Active
- Sponsor
- Erasmus MC
- Start
- Oct 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, single-blind trial of filgotinib in rheumatoid arthritis (RA) (2 arms), sponsored by Erasmus MC. Primary endpoints: Composite clinical effectiveness outcome, Disease Activity Score over time and 1 more. Started Oct 2020; status: active.
02
Drugs
filgotinib
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on 2020-002802-21.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-002802-21.